US Patent Issued to DANATLAS PHARMACEUTICALS on July 21 for "Tricyclic heterocyclic derivatives, compositions and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,683, issued on July 21, was assigned to DANATLAS PHARMACEUTICALS Co. LTD. (Beijing).

"Tricyclic heterocyclic derivatives, compositions and uses thereof" was invented by Wenlai Zhou (Beijing), Jincong Zhuo (Beijing), Yao Zhang (Beijing), Zhangqi Yu (Beijing) and Dan Yan (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to tricyclic heterocyclic derivatives as shown in Formula (I), to pharmaceutical compositions comprising them, to a process for their preparation, and their use as therapeutic agents."

The patent was filed on Aug. 24, 2025, under Application No. 19/308,305.

*For further information, including images, char...